Analyst Research

Report Title Price
Provider: Pechala's Reports
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cardiovascular Systems Inc Issues Q2 2013 Revenue Guidance Above Analysts' Estimates; Issues Q2 2013 Mixed Earnings Guidance


Tuesday, 30 Oct 2012 04:00pm EDT 

Cardiovascular Systems Inc announced that for the second quarter of 2013, it expects Revenue growth of 19% to 24% over the second quarter of fiscal 2012, to a range of $23.5 million to $24.5 million and net loss in the range of $(5.7) million to $(6.3) million, or loss per common share ranging from $(0.28) to $(0.30). According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $21.56 million, net income of $(5.6) and EPS of $(0.31) for the second quarter of 2013. 

Related Company News

Company Quote

26.08
-0.09 -0.34%
17 Apr 2014